A systematic review evaluates the efficacy and safety of Janus kinase and TYK2 inhibitors for treating generalized pustular psoriasis and palmoplantar pustulosis. The findings contribute to understanding treatment options for these rare skin conditions.
efficacy and safety of janus kinase and tyk2 inhibitors in the treatment of generalized pustular psoriasis and palmoplantar pustulosis a systematic review
Original title: “Efficacy and safety of Janus kinase and TYK2 inhibitors in the treatment of generalized pustular psoriasis and palmoplantar pustulosis: a systematic review.”